Pepticom Ltd. Their unique biocomputational AI software optimizes the drug discovery process, resulting in accelerated time to market, reduced development risks, and lower costs. Pepticom's mission is to unlock the hidden potential of peptide drugs and advance 21st-century medicine by improving access to novel peptide therapeutics.

By harnessing the power of AI, they are able to expand the exploration process to uncharted chemical space, providing more options and faster results. Their innovative approach involves Swarm Intelligence 2. 0, where bots with evolutionary mechanisms work collectively to identify better binding peptides.

Through the use of AI-driven reinforcement learning, search algorithms, smart grids, and scoring functions, Pepticom continuously discovers optimal peptides for target binding. With three forms of cyclization and flexible lengths ranging from 2 to 25 amino acids for linear peptides and 5 to 20 amino acids for cyclic peptides, Pepticom offers a wide range of options for peptide customization. Experience the future of drug discovery with Pepticom Ltd